(Q42944293)

11 November 2017

title

A lower Allred score for progesterone receptor is strongly associated with a higher recurrence score of 21-gene assay in breast cancer (English)

1 reference

11 November 2017

A Lower Allred Score for Progesterone Receptor Is Strongly Associated With a Higher Recurrence Score of 21-Gene Assay in Breast Cancer (English)

1 reference

https://api.crossref.org/works/10.3109/07357907.2010.496754

17 June 2024

author name string

Ping Tang

1

1 reference

11 November 2017

Jianmin Wang

2

1 reference

11 November 2017

Xi Wang

4

1 reference

11 November 2017

Linda Schiffhauer

5

1 reference

11 November 2017

Loralee McMahon

6

1 reference

11 November 2017

Qi Yang

7

1 reference

11 November 2017

Michelle Shayne

8

1 reference

11 November 2017

Alissa Huston

9

1 reference

11 November 2017

Jennifer Griggs

11

1 reference

11 November 2017

Gary Lyman

12

1 reference

11 November 2017

David G. Hicks

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20690804

17 June 2024

Kristin A. Skinner

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20690804

17 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20690804

17 June 2024

publication date

1 November 2010

1 reference

full work available at URL

11 November 2017

http://www.tandfonline.com/doi/pdf/10.3109/07357907.2010.496754

1 reference

https://api.crossref.org/works/10.3109/07357907.2010.496754

17 June 2024

1 reference

11 November 2017

volume

28

1 reference

11 November 2017

issue

9

1 reference

11 November 2017

page(s)

978-982

1 reference

An overview of prognostic factors for long-term survivors of breast cancer

11 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.496754

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.496754

Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.496754

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.496754

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.496754

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.496754

High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.496754

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.496754

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.496754

Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.496754

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.496754

Molecular classifications of breast carcinoma with similar terminology and different definitions: are they the same?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.496754

Impact of a 21-gene RT-PCR assay on treatment decisions in early-stage breast cancer: an economic analysis based on prognostic and predictive validation studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.496754

Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.496754

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.496754

Histopathologic variables predict Oncotype DX recurrence score

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.496754

Association between standard clinical and pathologic characteristics and the 21-gene recurrence score in breast cancer patients: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.496754

Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.496754

Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.496754

Progesterone receptor loss correlates with human epidermal growth factor receptor 2 overexpression in estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.496754

Progesterone Receptor Status Significantly Improves Outcome Prediction Over Estrogen Receptor Status Alone for Adjuvant Endocrine Therapy in Two Large Breast Cancer Databases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.496754

Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.496754

Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.496754

Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.496754

Intratumor heterogeneity of biomarker expression in breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.496754

Tissue microarray technology in the routine assessment of HER-2 status in invasive breast cancer: a prospective study of the use of immunohistochemistry and fluorescence in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.496754

Clinical outcome of adjuvant endocrine treatment according to PR and HER-2 status in early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.496754

Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer

21 January 2018

2

1 reference

https://api.crossref.org/works/10.3109/07357907.2010.496754

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer

17 June 2024

14

1 reference

https://api.crossref.org/works/10.3109/07357907.2010.496754

Predicting response to primary chemotherapy: gene expression profiling of paraffin-embedded core biopsy tissue

17 June 2024

21

1 reference

https://api.crossref.org/works/10.3109/07357907.2010.496754

Does oncotype DX recurrence score affect the management of patients with early-stage breast cancer?

17 June 2024

24

1 reference

https://api.crossref.org/works/10.3109/07357907.2010.496754

17 June 2024

Identifiers

1 reference

11 November 2017

1 reference